Funded Startups in San Clemente
The disclosed deals in San Clemente are highly top-heavy: Caretrust’s $509M round (2026-05-18) dwarfs the next-largest disclosed amount ($130M atVenu on 20…
The disclosed deals in San Clemente are highly top-heavy: Caretrust’s $509M round (2026-05-18) dwarfs the next-largest disclosed amount ($130M atVenu on 2024-10-08). The next tier sits below $75M, with AtaCor Medical at $75M (2025-10-06) and Sambazon at $45M (2021-05-19), suggesting a wide dispersion between a single mega-round and smaller follow-ons.
Timing clusters are also visible across the 2021-05-19 to 2026-07-22 window (11 rows shown, including 1 undisclosed): several large rounds cluster between 2024-09 and 2025-11 (atVenu $130M on 2024-10-08; Epica International $14M on 2024-09-17; Osteal Therapeutics $16M on 2025-11-05; AtaCor Medical $75M on 2025-10-06). Sector-wise, “Series Unknown” appears in most entries (6 of 11), spanning biotech (Osteal Therapeutics), health care (AtaCor Medical), and hardware (Epica International), while stage classifications vary widely (Seed: Low Rate Co. at $790K on 2025-11-21; Private Equity: Custom Flavors, undisclosed on 2026-07-22).
Most recent rounds
11 shownRelated listings
Frequently asked
What’s the largest disclosed round in San Clemente, and how does it compare to the rest of the disclosed amounts?
Caretrust’s $509M round (2026-05-18) is the largest disclosed amount and materially exceeds every other disclosed deal on the page, where the next-largest is $130M atVenu (2024-10-08). After that, the remaining disclosed amounts step down into the $75M to $4M range (e.g., AtaCor Medical $75M on 2025-10-06; The Marygold Companies $4M on 2024-09-24).
Do the rounds cluster in a narrow time window, or are they evenly spread across the date range?
They’re not evenly spread: the dataset spans 2021-05-19 to 2026-07-22, but multiple sizable rounds concentrate between late 2024 and 2025. Examples include atVenu $130M (2024-10-08), Epica International $14M (2024-09-17), Osteal Therapeutics $16M (2025-11-05), and AtaCor Medical $75M (2025-10-06).
Is “Series Unknown” the dominant stage classification in this city view?
Yes. “Series Unknown” appears in 6 of the 11 rows, including Osteal Therapeutics ($16M on 2025-11-05), AtaCor Medical ($75M on 2025-10-06), and Epica International ($14M on 2024-09-17). The other stages shown are Seed (Low Rate Co. at $790K on 2025-11-21), Private Equity (Custom Flavors, undisclosed on 2026-07-22), and “Series Unknown” does not apply to Caretrust, which is listed as “Series Unknown” as well but with a disclosed $509M (2026-05-18) in the table.
Which companies look like outliers by disclosed amount size?
The main size outlier is Caretrust at $509M (2026-05-18), which sits far above the rest of the disclosed ladder. On the low end, the smallest disclosed amount is Nomadix at $400K (2022-04-07), well below other mid-to-upper disclosed rounds like Project 7 at $30M (2025-06-04) and The Marygold Companies at $4M (2024-09-24).
Are any sectors especially represented among the companies listed for San Clemente?
Within the 11 rows shown, there isn’t a single sector that appears three or more times; each listed sector (e.g., Biotechnology for Osteal Therapeutics, Hardware for Epica International, Health Care for AtaCor Medical) shows as a unique label in this snippet. The closest pattern is sector diversity alongside a common classification label: many “Series Unknown” entries span different sector labels rather than repeating one sector.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.